Bone turnover markers: basic biology to clinical applications

M Schini, T Vilaca, F Gossiel, S Salam… - Endocrine …, 2023 - academic.oup.com
Bone turnover markers (BTMs) are used widely, in both research and clinical practice. In the
last 20 years, much experience has been gained in measurement and interpretation of these …

Management of endocrine disease: secondary osteoporosis: pathophysiology and management

F Mirza, E Canalis - European journal of endocrinology, 2015 - academic.oup.com
Osteoporosis is a skeletal disorder characterized by decreased mass and compromised
bone strength predisposing to an increased risk of fractures. Although idiopathic …

Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial

PJ Snyder, DL Kopperdahl… - JAMA internal …, 2017 - jamanetwork.com
Importance As men age, they experience decreased serum testosterone concentrations,
decreased bone mineral density (BMD), and increased risk of fracture. Objective To …

Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone …

DA Galvao, DR Taaffe, N Spry, D Joseph… - Journal of clinical …, 2010 - ascopubs.org
Purpose Androgen suppression therapy (AST) results in musculoskeletal toxicity that
reduces physical function and quality of life. This study examined the impact of a combined …

Osteoporosis in men: an Endocrine Society clinical practice guideline

NB Watts, RA Adler, JP Bilezikian… - The Journal of …, 2012 - academic.oup.com
Objective: The aim was to formulate practice guidelines for management of osteoporosis in
men. Evidence: We used the Grading of Recommendations, Assessment, Development, and …

Long-term evaluation of cross-sex hormone treatment in transsexual persons

K Wierckx, S Mueller, S Weyers… - The journal of sexual …, 2012 - academic.oup.com
Introduction Long-term effects and side effects of cross-sex hormone treatment in
transsexual persons are not well known. Aim The aim of this study is to describe the effects …

[图书][B] Yen & Jaffe's Reproductive Endocrinology-E-Book: Physiology, Pathophysiology, and Clinical Management

JF Strauss, RL Barbieri, A Dokras, CJ Williams… - 2023 - books.google.com
For over 40 years, Yen & Jaffe's Reproductive Endocrinology has been the gold standard
text of both basic science and clinical practice of the full range of female and male …

Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review

JR Gardner, PM Livingston, SF Fraser - Journal of Clinical Oncology, 2014 - ascopubs.org
Purpose Androgen-deprivation therapy is a commonly used treatment for men with prostate
cancer; however, the adverse effects can be detrimental to patient health and quality of life …

[HTML][HTML] Muscle dysfunction in cancer patients

JF Christensen, LW Jones, JL Andersen, G Daugaard… - Annals of oncology, 2014 - Elsevier
Background Muscle dysfunction is a prevalent phenomenon in the oncology setting where
patients across a wide range of diagnoses are subject to impaired muscle function …

Contemporary role of androgen deprivation therapy for prostate cancer

V Pagliarulo, S Bracarda, MA Eisenberger, N Mottet… - European urology, 2012 - Elsevier
CONTEXT: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of
the most effective systemic palliative treatments known for solid tumors. Although clinical …